Roivant Sciences (NasdaqGS:ROIV) Update / briefing Transcript

Roivant Sciences (NasdaqGS:ROIV) Update / briefing March 03, 2026 04:45 PM ET Company ParticipantsDouglas Tsao - Managing Director of Equity ResearchMatt Gline - CEOSarah Cai - Biotechnology Equity Research AssociateStephanie Lee Griffin - COO of Roivant PlatformsYatin Suneja - Senior Managing DirectorConference Call ParticipantsAndy Chen - Managing Director and Senior Equity Research AnalystBrian Cheng - Executive Director and Senior Biotech AnalystChi Meng Fong - VP and Research AnalystDavid Risinger - Se ...